TY - JOUR
T1 - Boosting the autophagy-lysosomal pathway by phytochemicals
T2 - A potential therapeutic strategy against Alzheimer's disease
AU - Nourbakhsh, Fahimeh
AU - Read, Morgayn I.
AU - Barreto, George E.
AU - Sahebkar, Amirhossein
N1 - Publisher Copyright:
© 2020 International Union of Biochemistry and Molecular Biology
PY - 2020/11/1
Y1 - 2020/11/1
N2 - The lysosome is a membrane-enclosed organelle in eukaryotic cells, which has basic pattern recognition for nutrient-dependent signal transduction. In Alzheimer's disease, the already declining autophagy-lysosomal function is exacerbated by an increased need for clearance of damaged proteins and organelles in aged cells. Recent evidence suggests that numerous diseases are linked to impaired autophagy upstream of lysosomes. In this way, a comprehensive survey on the pathophysiology of the disease seems necessary. Hence, in the first section of this review, we will discuss the ultimate findings in lysosomal signaling functions and how they affect cellular metabolism and trafficking under neurodegenerative conditions, specifically Alzheimer's disease. In the second section, we focus on how natural products and their derivatives are involved in the regulation of inflammation and lysosomal dysfunction pathways, including how these should be considered a crucial target for Alzheimer's disease therapeutics.
AB - The lysosome is a membrane-enclosed organelle in eukaryotic cells, which has basic pattern recognition for nutrient-dependent signal transduction. In Alzheimer's disease, the already declining autophagy-lysosomal function is exacerbated by an increased need for clearance of damaged proteins and organelles in aged cells. Recent evidence suggests that numerous diseases are linked to impaired autophagy upstream of lysosomes. In this way, a comprehensive survey on the pathophysiology of the disease seems necessary. Hence, in the first section of this review, we will discuss the ultimate findings in lysosomal signaling functions and how they affect cellular metabolism and trafficking under neurodegenerative conditions, specifically Alzheimer's disease. In the second section, we focus on how natural products and their derivatives are involved in the regulation of inflammation and lysosomal dysfunction pathways, including how these should be considered a crucial target for Alzheimer's disease therapeutics.
KW - Alzheimer's disease
KW - lysosomal dysfunction
KW - natural products
KW - neurodegenerative diseases
UR - http://www.scopus.com/inward/record.url?scp=85090314310&partnerID=8YFLogxK
U2 - 10.1002/iub.2369
DO - 10.1002/iub.2369
M3 - Review article
C2 - 32894821
AN - SCOPUS:85090314310
SN - 1521-6543
VL - 72
SP - 2360
EP - 2281
JO - IUBMB Life
JF - IUBMB Life
IS - 11
ER -